ALS Research Update | March 2019

Bringing you the latest news on advancements in ALS research, the ALS Canada Research Program team regularly summarizes what they believe are the most significant discoveries throughout the year. This is the first update for 2019. Researchers identify a potential new biomarker and drug target for ALS Did you know that there is a protein […]

What’s the story with CuATSM

This article was originally posted on the Motor Neurone Disease Association research blog on January 15, 2019. Thank you to the author Dr. Nicholas Cole, Head of Research, as well as the Motor Neuron Disease Association for giving ALS Canada permission to re-post this content.   There has recently been a flood of news stories […]

Wrapping up the holiday giving season

2018 was a momentous year for the ALS community. Discoveries were made that advance our understanding of the disease, clinical trials showed encouraging results, and the first therapy in over 20 years was approved for use in Canada for people living with ALS. Yet in the same year, ALS continued to take countless moments and […]

ALS Canada Strengthens Partnerships Within the Health Charities Sector

ALS Canada is proud to share that Tammy Moore, CEO ALS Canada, has been named Chair of the Board of Directors for the Health Charities Coalition of Canada (HCCC). ALS Canada’s ongoing membership with HCCC helps to bring the perspective of the ALS community to the broader advocacy efforts of health charities in support of […]

A Community Connected

In 2014, the Ice Bucket Challenge gave hope to people and families living with ALS – hope that one day there would be a cure for this terminal disease. With the Ice Bucket Challenge came an immense responsibility to invest donor dollars with care and consideration, and as a result, ALS Canada’s investments have helped […]